Skip to content

Clinical trials

Observational Carcinoma, Intraductal, Noninfiltrating trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Intraductal, Noninfiltrating Phase: Observational Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20062
20084
20095
20101
20112
20132
20142
20161
20172
20183
20192
20201
20222
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting5
Unknown status2
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic4
University of Nebraska3
Dana-Farber Cancer Institute2
Wake Forest University Health Sciences2
Yale University2
Atossa Therapeutics, Inc.1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Concure Oncology-Breast Microseed Inc.1
Dartmouth-Hitchcock Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Intraductal, Noninfiltrating38
Breast Neoplasms28
Breast Carcinoma In Situ11
Carcinoma, Lobular4
Neoplasms3
Carcinoma, Ductal, Breast2
Pain2
Precancerous Conditions2
Anxiety Disorders1
Breast Diseases1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.